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Sir, We thank Kariuki and Newton for their letter which raises
several interesting points. We value their contributions to this
discussion.
Failure of cerebral autoregulation may be an important step in the
cerebral malaria disease process. Ideally our review would have not
only included comparisons of autoregulatory function in retinal and
cerebral vessels, but also other important subjects such as the nature
of the blood-tissue barriers, distribution of endothelial receptors, and
vessel ultrastructure in retina and brain. Comparing and contrasting
the retina with other areas of the CNS in terms of these and
other features could well provide valuable insights, not just into
cerebral malaria, but for a whole range of neurovascular diseases.
We hope our paper will help to stimulate individual reviews on these
topics.
The utility of Plasmodium falciparum histidine-rich protein 2
(pfHRP2) as a biomarker in severe malaria has recently been re-
viewed (Manning and Davis, 2013). In African children with severe
malaria, high pfHRP2 has been associated with anaemia, coma and
death (Hendriksen et al., 2012), and distinguishes presence/absence
of cerebral sequestration or malarial retinopathy in separate deriv-
ation and validation cohorts (Seydel et al., 2012). pfHRP2 shows
clear promise as an important indicator of P. falciparum pathogen-
esis, and further evaluation as a biomarker of disease severity
seems warranted. However, as with any prospective biomarker,
evaluation must consider the biological context (Buyse et al.,
2010). For example, some strains of P. falciparum do not
produce pfHRP2 (Gamboa et al., 2010). Estimates of total body
parasite load may provide useful information at a population
level, but subject level variance in important biological parameters
leads to improbable values for individual patients (Hendriksen et al.,
2012).
Biological context is equally important when considering retinal
features as potential markers of cerebral damage. This concern
motivated our review. The available evidence suggests that mal-
arial retinopathy, in the context of clinically defined paediatric
cerebral malaria (Newton et al., 1998), does indeed reflect similar
disease processes in the brain. Although empirical associations be-
tween retinopathy and cerebral histopathology necessarily come
from limited populations, similarities between retina and brain in
terms of anatomy and physiology imply that these associations are
also likely to exist more broadly. This biological context suggests
inference of several distinct pathological processes from the retina
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to the brain is plausible, including sequestration, haemorrhage,
blood-tissue barrier breakdown, and ischaemia (MacCormick
et al., 2014). Consequently, retinal imaging in severe malaria
has the potential to provide information on a range of inter-
dependent pathological processes, taking place within the CNS.
In the same way that parasite detection by microscopy depends
on an experienced technician, accurate detection of malarial retin-
opathy depends on the observer and the method. There is a need for
a standardized approach to malarial retinopathy. This will facilitate
accurate comparisons between studies, and help to define the
characteristics and clinical associations of both malarial retinopathy
and cerebral malaria more generally. Progressive technological ad-
vances in retinal imaging are likely to increase the utility of retinal
observations.
Far from precluding the use of other disease markers, retinal
imaging represents an opportunity to assess novel biomarkers,
both for their clinical use and to investigate relationships between
multiple aspects of cerebral pathogenesis. More work is needed to
compare retina–brain biological characteristics, describe empirical
associations between retina, brain, and prospective biomarkers
(including pfHRP2), and to standardize imaging methodology in
malaria research.
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